{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T17:28:46Z","timestamp":1649006926676},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00105-021-04821-5","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T20:03:34Z","timestamp":1619035414000},"page":"303-307","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Calprotectin\u00a0\u2013 ein Schl\u00fcssel zur Diagnose einer chronisch entz\u00fcndlichen Darmerkrankung bei entz\u00fcndlichen Dermatosen?"],"prefix":"10.1007","volume":"73","author":[{"given":"E.","family":"Koutra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lusm\u00f6ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"key":"4821_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/ajg.2010.343","volume":"106","author":"SR Vavricka","year":"2011","unstructured":"Vavricka\u00a0SR, Brun\u00a0L, Ballabeni\u00a0P et\u00a0al (2011) Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 106:110","journal-title":"Am J Gastroenterol"},{"key":"4821_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/00005792-197609000-00004","volume":"55","author":"AJ Greenstein","year":"1976","unstructured":"Greenstein\u00a0AJ, Janowitz\u00a0HD, Sachar\u00a0DB (1976) The extraintestinal complications of Crohn\u2019s disease and ulcerative colitis: a\u00a0study of 700 patients. Medicine 55:401","journal-title":"Medicine"},{"issue":"5","key":"4821_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/MD.0b013e318187cc9c","volume":"87","author":"D Farhi","year":"2008","unstructured":"Farhi\u00a0D, Cosnes\u00a0J, Zizi\u00a0N, Chosidow\u00a0O, Seksik\u00a0P, Beaugerie\u00a0L, Aractingi\u00a0S (2008) Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases. Medicine 87(5):281\u2013229","journal-title":"Medicine"},{"key":"4821_CR4","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1007\/s00105-016-3894-z","volume":"67","author":"L Richter","year":"2016","unstructured":"Richter\u00a0L, Rappersberger\u00a0K (2016) Hauterscheinungen bei CED, Morbus Crohn und Colitis ulcerosa. Hautarzt 67:940\u2013947. https:\/\/doi.org\/10.1007\/s00105-016-3894-z","journal-title":"Hautarzt"},{"key":"4821_CR5","volume-title":"Calprotectin als Surrogatmarker der entz\u00fcndlichen Aktivit\u00e4t CED","author":"AK Kl\u00fcver","year":"2018","unstructured":"Kl\u00fcver AK (2018) Calprotectin als Surrogatmarker der entz\u00fcndlichen Aktivit\u00e4t CED. Zentrum f\u00fcr Innere Medizin, Universit\u00e4t Hamburg, Hamburg"},{"key":"4821_CR6","unstructured":"Aktualisierte S3-Leitlinie: Diagnostik und Therapie des Morbus Crohn, Bayerisches \u00c4rzteblatt 9\/2015"},{"key":"4821_CR7","unstructured":"S3-Leitlinie 021\/004: Diagnostik und Therapie des Morbus Crohn, aktueller Stand 01\/2014"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04821-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-021-04821-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04821-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T22:03:20Z","timestamp":1648591400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-021-04821-5"}},"subtitle":["Drei Kasuistiken"],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["4821"],"URL":"https:\/\/doi.org\/10.1007\/s00105-021-04821-5","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,21]]},"assertion":[{"value":"26 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"E.\u00a0Koutra, E.\u00a0Lusm\u00f6ller und R.\u00a0Stadler geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}